title: [Essential facial neuralgia with bilateral involvement: apropos of a case seen at the Cité Verte Hospital in Yaoundé].
abstract: Despite the fact that essential facial neuralgia is a well known clinical entity as relates to its evolution and treatment, its physiopathology is still a controversial issue. The form with bilateral evolution that we observed and that we are reporting here is extremely rare and its physiopathology is even more controversial. The case of our patient is all the more complicated in that, the pain topography is limited to the right to a sensitive region of the trigeminal nerve (superior maxillary) and to the left to the region of the mandible (inferior maxillary) A similar disease evolution is not described so far in the present literature of the disease. We have therefore seized this opportunity to out line the possible causes of faulty diagnosis in order that essential facial neuralgia should not be labelled as facial pain of tumoral, vascular or other origin.
authors.affiliation: U.F.R d'odontostomatologie, Université de Bordeaux 2-France.
authors.forename: A
authors.initials: A
authors.lastname: Djoumessi
authors.forename: E M
authors.initials: EM
authors.lastname: Mendomo
authors.forename: J
authors.initials: J
authors.lastname: Onana
authors.forename: S
authors.initials: S
authors.lastname: Djoumessi
authors.forename: Ph
authors.initials: P
authors.lastname: Ndobo-Epoy
mesh_terms: D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001418:Baclofen / Q000627:therapeutic use; D001569:Benzodiazepines; D005156:Facial Neuralgia / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008340:Mandibular Nerve / Q000503:physiopathology; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D014276:Trigeminal Nerve / Q000503:physiopathology
chemical_list: D014151:Anti-Anxiety Agents; D009125:Muscle Relaxants, Central; D001569:Benzodiazepines; D001418:Baclofen